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ABSTRACT 
Objective: Synthesis of novel 4-(5-substituted amino methyl)-1H-tetrazol-1-yl)benzonitriles from p-aminobenzonitrile 
Methods: A series of novel 4-(5-substituted amino methyl)-1H-tetrazol-1-yl)benzonitriles 6(a-f) were prepared starting from p-aminobenzonitrile 
1which is protected with acetoxyacetylchloride, and followed by tetrazole formation with CH3SiN3 in DIAD/TPP conditions to form the 1-(4-
cyanophenyl)-1H-tetrazol-5-yl) methyl acetate 3. This compound was hydrolyzed, followed by chlorination and treated with different amines to 
produce the title compounds.  
Results: All structures of the newly synthesized compounds were confirmed by IR, NMR, mass spectral studies, and elemental analyses.  
Conclusion: We developed a simple and efficient method for the preparation of 4-(5-substituted amino methyl)-1H-tetrazol-1-yl)benzonitriles form 
p-aminobenzonitrile through protection, tetrazole formation, hydrolysis, chlorination and amination as key steps with good yields and this method 
is highly useful for the synthesis of biologically potent highly substituted tetrazole derivatives.  
Keywords: Acetoxyacetylchloride, Aminobenzonitrile, Trimethylsilylazide, Tetrazole. 
 
INTRODUCTION 
Hetrocyclic compounds are considered as the most promising 
molecules for the design of new drug. Tetrazoles are a class of 
heterocycles with a wide range of applications that are receiving 
considerable attention [1]. The synthesis of novel tetrazole 
derivatives and the investigation of their chemical and biological 
behavior have gained more importance in the recent decades for 
biological and pharmaceutical reasons. Recently, several biologically 
relevant substances incorporating a tetrazole moiety have been 
developed, for example losartan is an angiotensin II receptor 
antagonist [2], Tomelukast (L-171883) mimics the cysteinyl glycine 
terminus of growth hormone LTD 4, also functions as a potent anti 
asthmatic drug [3] and BMS-317180 is a potent oral agonist of the 
human growth hormone secretagogue (GHS) receptor [4]. They have 
found use in pharmaceuticals as lipophilic spacers and carboxylic 
acid surrogates, which improves oral absorption [5]. Their 
derivatives were also reported to possess broad spectrum of 
biological activity in both medicinal and pharmaceutical areas such 
as antinociceptive [6], antibacterial [7], antifungal [8], anti-HIV, 
anticancer, immunosuppressive [9], anti-inflammatory [10], 
antiulcer [11], antiproliferative [12], antiallergic [13] and 
antianalgesic [14] activities. The tetrazole function is metabolically 
stable and a close similarity between the acidic character of the 
tetrazole group and carboxylic acid group have inspired medicinal 
chemists to synthesize substituted tetrazoles as potential medicinal 
agents. Various methodologies for preparing compounds with a 
tetrazole ring system have been developed, among the most 
important are those based on azides on cyanide reactions. 
Prompted by these observations, and as part of our research 
program aimed at developing new biologically active heterocycles, 
in this paper, we designed a simple synthetic method for the 
synthesis of substituted 4-(5-aminomethyl)-1H-tetrazol-1-yl) 
benzonitriles by the reaction of protected amines with TMSiN3 
followed by hydrolysis, chlorination and amination. 
MATERIAL AND METHODS 
Melting points were recorded on a Stuart SMP30 melting point 
apparatus and were uncorrected. Column chromatography was 
performed using silica–gel (100–200 mesh size) purchased from 
Thomas Baker, and thin layer chromatography (TLC) was carried 
out using aluminium sheets pre-coated with silica gel 60F254 
purchased from Merck. IR spectra (KBr) were obtained using a 
Perkin Elmer Spectrum100 FTIR spectrometer. 1H NMR (400 MHz) 
and [13]C NMR (100 MHz) spectra were recorded on a Bruker WM-
400 spectrometer in DMSO-d6 with TMS as an internal standard. 
Mass spectra (ESI) were carried out on a JEOL SX-102 spectrometer. 
CHN analysis was done by Carlo Erba EA 1108 automatic elemental 
analyzer. The chemicals and solvents used were of commercial grade 
and were used without further purification unless otherwise stated. 
General Procedures 
Synthesis of 2-(4-cyanophenylamino)-2-oxoethyl acetate 2 
To a stirred solution of 4-amino benzonitrile 1 (0.68 mol) in DCM as 
solvent, triethyl amine (TEA) (3.0 mol) was added at 0°C and stirred 
for 15 min. Then acetoxyacetylchloride (1.20 mol) was added at 0°C 
slowly and stirred for 4 h at room temperature. Completion of the 
reaction was followed by TLC. The reaction mixture was diluted with 
water, extracted with DCM, washed with saturated NaHCO3 (2×5 ml) 
solution, dried over anhydrous sodium sulphate and concentrated 
under reduced pressure to get crude. The crude was purified by a 
column chromatography using silica gel (60-120 mesh) with EtOAc-
Pet ether (2:8) furnished compound 2. 
Yield: 80 %; IR (KBr, cm-1): 1,682, 1,728, and 2,232. 1H NMR (DMSO-
d6, 400 MHz): δ 2.15 (s, 3H,-CH3), 4.68 (s, 2H,-CH2), 7.02–7.69 (m, 4H, 
Ar-H), 10.5 (s, 1H,-NH) ppm. [13]C NMR (DMSO-d6, 100 MHz): δ 
21.98, 66.37, 110.14, 120.20, 124.34, 134.77, 143.51, 170.72, 172.75 
ppm. ESI–MS (m/z): 218 (M+1). Anal. Calcd for C11H10N2O3: C, 60.55; 
H, 4.62; N, 12.84. Found: C, 60.52; H, 4.57; N, 12.76.  
Synthesis of 1-(4-cyanophenyl)-1H-tetrazol-5-yl) methyl 
acetate 3 
To a solution of compound 2 (0.298 mol) in THF, 
Triphenylphosphine (TPP) (0.74 mol) and Diisopropyl 
azodicorboxylate (DIAD) (0.74 mol) were added at 0°C and stirred 
the reaction mixture for 30 min. Trimethylsiliylazide (0.74 mol) was 
added drop wise at room temperature, refluxed for overnight. 
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Completion of the reaction was monitored by TLC. After completion 
the reaction mixture was diluted with EtOAc, washed with ice cold 
water, separated organic layer, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to afforded the crude which 
was purified by column chromatography over 60-120 mesh silica gel 
by using 30% ethyl acetate-pet ether as solvent yielded the 
corresponding compound 3.  
Yield: 64 %; IR (KBr, cm-1): 1,678, 2,228; 1H NMR (DMSO-d6, 400 
MHz): δ 2.05 (s, 3H,-CH3), 5.40 (s, 2H,-CH2), 7.90 (d, 2H, Ar-H), 8.20 
(d, 2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 100 MHz): δ 22.04, 66.89, 
113.76, 121.42, 124.45, 134.56, 139.54, 162.24, 172.25 ppm. ESI–MS 
(m/z): 244 (M+1). Anal. Calcd for C11H9N5O2: C, 54.32; H, 3.73; N, 
28.79. Found: C, 54.26; H, 3.65; N, 28.70.  
Synthesis of 4-(5-(hydroxy methyl)-1H-tetrazol-1-yl) 
benzonitrile 4 
To solution of compound 3 (0.185 mol) in THF/methanol/water 
(2:1:1), Lithium hydroxide (0.277 mol) was added at 0°C slowly than 
stirred the reaction mixture for 30 minutes at room temperature. 
The completion of reaction was followed by TLC. After completion, 
solvent was removed under reduced pressure; reaction mixture was 
diluted with DCM and washed with ice water. Separated the DCM 
layer and dried over anhydrous Na2SO4, concentrated under reduced 
pressure to afford the residue. The residue was purified by a column 
chromatography using 100-200 mesh silica gel with 50% EtOAc-pet 
ether get pure product 4-(5-(hydroxy methyl)-1H-tetrazol-1-yl) 
benzonitrile 4 as a white solid.  
Yield: 96.7 %; IR (KBr, cm-1): 3,380, 2,232: 1H NMR (DMSO-d6, 400 
MHz): δ 4.80-4.85 (d, 2H,-CH2), 6.01(t, 1H,-OH), 7.98 (d, 2H, Ar-H), 
8.18 (d, 2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 100 MHz): δ 55.23, 
113.62, 119.24, 125.52, 134.92, 138.44, 163.40 ppm. ESI–MS (m/z): 
201 (M+1). Anal. Calcd for C9H7N5O: C, 53.73; H, 3.51; N, 34.81. 
Found: C, 53.64; H, 3.45; N, 34.78.  
Synthesis of 4-(5-(chloromethyl)-1H-tetrazol-1-yl)benzonitrile 5 
To a stirred solution of compound 4 (0.179 mol) in toluene, 
thionyl chloride (0.197 mol) was added at room temperature and 
stirred the reaction mixture for 3 h at reflux temperature. 
Completion of the reaction was followed by TLC. Reaction mixture 
was concentrated under vacuo, reaction mixture was poured into 
ice-cold water and extracted with EtOAc. Collected the the organic 
layers, washed with aqueous NaHCO3 solution, dried over 
anhydrous Na2SO4, concentrated under reduced pressure to afford 
crude compound. The crude compound was purified by a column 
chromatography using 100-200 mesh silica gel with 30% EtOAc-
pet ether furnished the pure product 5. 
Yield: 52.0 %; IR (KBr, cm-1): 2,228. 1H NMR (DMSO-d6, 400 MHz): δ 
5.2 (s, 2H,-CH2), 8.19 (d, 2H, Ar-H) 8.20 (d, 2H, Ar-H) ppm. [13]C NMR 
(DMSO-d6, 100 MHz): δ 35.43, 113.78, 119.67, 125.92, 134.67, 138.96, 
164.28 ppm. ESI–MS (m/z): 220 (M+1). Anal. Calcd for C9H6N5Cl: C, 
49.22; H, 2.75; N, 31.89. Found: C, 49.18; H, 2.69; N, 31.82.  
Synthesis of substituted 4-(5-aminomethyl)-1H-tetrazol-1-yl) 
benzonitriles 6(a-f) 
The compound 5 (0.01 mol) was dissolved in DMF, stirred the 
reaction mixture for few minutes and added aliphatic and 
substituted aromatic amines (a-f), than heated to reflux 
temperature for 4-5 h. Completion of the reaction was monitored by 
TLC, after completion the reaction mixture was concentrated under 
vacuo, the reaction mixture was poured into ice-cold water and 
extracted with chloroform, separated the organic layer, washed with 
water, dried over anhydrous Na2SO4, concentrated under reduced 
pressure to afford crude compound. The crude compound was 
purified by a column chromatograph furnished the pure products. 
6a: 4-(5-aminomethyl)-1H-tetrazol-1-yl) benzonitrile 
Yield: 65.0 %; IR (KBr, cm-1): 3,374, 2,230; 1H NMR (DMSO-d6, 400 
MHz): δ 3.2 (s, 3H,-CH3), 5.18 (s, 2H,-CH2), 7.92 (d, 2H, Ar-H), 8.10 (d, 
2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 100 MHz): δ 36.23, 49.24, 
113.78, 119.27, 126.52, 135.24, 138.62, 165.12 ppm. ESI–MS (m/z): 
215 (M+1). Anal. Calcd for C10H10N6: C, 56.07; H, 4.71; N, 39.23. 
Found: C, 56.01; H, 4.62; N, 39.18.  
6b: 4-(5-aminoethyl)-1H-tetrazol-1-yl) benzonitrile 
Yield: 62.5 %; IR (KBr, cm-1): 3,382, 2,232; 1H NMR (DMSO-d6, 400 
MHz): δ 1.23 (t, 3H,-CH3), 2.78 (q, 2H,-CH2), 5.24 (s, 2H,-CH2), 7.98 (d, 
2H, Ar-H), 8.12 (d, 2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 100 MHz): 
δ 17.24, 45.68, 46.32, 113.82, 119.32, 125.82, 135.46, 138.22, 166.22 
ppm. ESI–MS (m/z): 229 (M+1). Anal. Calcd for C11H12N6: C, 57.88; H, 
5.30; N, 36.82. Found: C, 57.80; H, 5.21; N, 36.76.  
6c: 4-(5-aminophenyl)-1H-tetrazol-1-yl) benzonitrile 
Yield: 59.0 %; IR (KBr, cm-1): 3,398, 2,230; 1H NMR (DMSO-d6, 400 
MHz): δ 5.26 (s, 2H,-CH2), 6.78-7.22 (m, 5H, Ar-H), 7.82 (d, 2H, Ar-H), 
8.02 (d, 2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 100 MHz): δ 44.52, 
113.82, 114.24, 119.32, 125.82, 130.25, 130.32, 130.88, 136.72, 
137.42, 165.42 ppm. ESI–MS (m/z): 277 (M+1). Anal. Calcd for 
C15H12N6: C, 65.21; H, 4.38; N, 30.42. Found: C, 65.15; H, 4.29; N, 30.34.  
6d: 4-(5-((2-methoxyphenylamino)methyl-1H-tetrazol-1-yl) 
benzonitrile 
Yield: 67.0 %; IR (KBr, cm-1): 3,392, 2,232; 1H NMR (DMSO-d6, 400 
MHz): δ 3.86 (s, 3H,-OCH3) 5.22 (s, 2H,-CH2), 6.82-7.12 (m, 4H, Ar-H), 
7.92 (d, 2H, Ar-H), 8.12 (d, 2H, Ar-H) ppm. [13]C NMR (DMSO-d6, 
100 MHz): δ 42.28, 58.24, 113.80, 114.24, 117.27, 119.62, 122.40, 
126.18, 135.26, 137.12, 140.48, 145.25, 165.42 ppm. ESI–MS (m/z): 
307 (M+1). Anal. Calcd for C16H14N6O: C, 62.74; H, 4.61; N, 27.44. 
Found: C, 62.68; H, 4.59; N, 27.39.  
6e: 4-(5-((4-chlorophenylamino) methyl-1H-tetrazol-1-yl) 
benzonitrile 
Yield: 70.0 %; IR (KBr, cm-1): 3390, 2234: 1H NMR (DMSO-d6, 400 
MHz): δ 5.18 (s, 2H,-CH2), 6.78-6.82 (dd, 2H, Ar-H), 7.42-7.50 (dd, 
2H, Ar-H), 7.94 (d, 2H, Ar-H), 8.12 (d, 2H, Ar-H) ppm. [13]C NMR 
(DMSO-d6, 100 MHz): δ 42.20, 113.42, 115.20, 119.24, 124.36, 
127.25, 130.65, 134.16, 138.65, 149.59, 161.34 ppm. ESI–MS (m/z): 
311 (M+1). Anal. Calcd for C15H11N6Cl: C, 57.98; H, 3.57; N, 27.05. 
Found: C, 57.92; H, 3.52; N, 26.94.  
6f: 4-(5-((4-bromophenylamino) methyl-1H-tetrazol-1-yl) 
benzonitrile 
Yield: 72.0 %; IR (KBr, cm-1): 3,386, 2,234; 1H NMR (DMSO-d6, 400 
MHz): δ 5.20 (s, 2H,-CH2), 6.72-6.84 (dd, 2H, Ar-H), 7.52-7.58 (dd, 
2H, Ar-H), 7.98 (d, 2H, Ar-H), 8.18 (d, 2H, Ar-H) ppm. [13]C NMR 
(DMSO-d6, 100 MHz): δ 42.42, 113.62, 115.20, 119.27, 124.35, 
128.32, 131.54, 134.92, 138.62, 149.92, 162.48 ppm. ESI–MS (m/z): 
355 (M+1). Anal. Calcd for C15H11N6Br: C, 50.72; H, 3.12; N, 23.66. 
Found: C, 50.69; H, 3.06; N, 23.60.  
RESULTS AND DISCUSSION 
The reaction sequences employed for the synthesis of compounds 
6(a–f) are shown in Scheme 1. The compound p-amino benzonitrile 
1 protected with acetoxyacetylchloride to form 2-(4-cyano 
phenylamino)-2-oxoethyl acetate 2 which is reacted with TMSiN3 in 
the presence of DIAD/TPP gave corresponding tetrazole compound 
3. This compound was hydrolyzed with LiOH than followed by 
chlorinated with thionyl chloride gave the corresponding compound 
4-(5-(chloro methyl)-1H-tetrazol-1-yl)benzonitrile 5. Further 
compound 5 reacted with different amines (a-f) in the presence of 
basic conditions respectively.  
The structures of all the newly synthesized compounds 6(a-f) were 
established by IR, NMR and mass spectral data. In IR spectra, the 
presence of –NH band at 3,374–3,394 cm-1 and a sharp absorption 
band (-CN) around 2,230 cm-1 showed the formation of tetrazole, 
only on amine group but not cyano group, while 1H NMR showed a 
singlet at δ 10.32–10.61 ppm due to the –NH proton and all other 
aromatic/aliphatic protons were observed at the expected regions. 
The mass spectra detected the expected molecular ion signals 
corresponding to respective molecular formula of the synthesized 
compounds. The elemental analyses values were in good agreement 
with the theoretical data are given in the experimental section. 
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Scheme 1: Synthesis of substituted 4-(5-aminomethyl)-1H-
tetrazol-1-yl) benzonitriles 6(a-f) 
Conditions: a) CH3COOCH2COCl 
(acetoxyacetylchloride)/TEA/DCM; b) Me3SiN3 / DIAD /TPP; c) 
LiOH/EtOH/ H2O; d) SOCl2/Toluene; e)anhyd. K2CO3/ DMF, R=-Me, 
Ethyl, Phenyl, 2-Methoxyphenyl, p-Chloro phenyl, p-Bromo phenyl 
 
CONCLUSION 
In conclusion, we have developed a simple and efficient method for 
the preparation of 4-(5-substituted amino methyl)-1H-tetrazol-1-
yl)benzonitriles form p-aminobenzonitrile through protection, 
tetrazole formation, hydrolysis, chlorination and amination as key 
steps. Further research and applications of the reactions are in 
progress in our laboratories. We believe that this method is highly 
useful for the synthesis of biologically potent highly substituted 
tetrazole derivatives.  
CONFLICT OF INTERESTS 
Declared None  
REFERENCES 
1. Butler RN, Katritzky AR, Rees CW, Scriven EFV. Comprehensive 
Heterocyclic Chemistry: Vol. 4: Pergamon Press, Oxford, UK; 
1996. 
2. García G, Rodríguez-Puyol M, Alajarín R, Serrano I, Sánchez-
Alonso P, Griera M, et al. Losartan-antioxidant hybrids: novel 
molecules for the prevention of hypertension-induced 
cardiovascular damage. J Med Chem 2009:52:7220-7.  
3. Chu SS, Cannon JR, Eacho PI. Biochem J 1991:280:387-91. 
4. Davulcu A, Mc Leod D, Li J, Katipally K, Littke A, Doubleday W, 
et al. Process research and development for a tetrazole-based 
growth harmone secretagogue (ghs) pharmaceutical 
devolopment candidate. J Org Chem 2009:74(11):4068-79. 
5. Herr RJ. 5-Substituted-1H-tetrazoles as carboxylic acid 
isosteres: medicinal chemistry and synthetic methods. Bioorg 
Med Chem 2002:10(11):3379–93. 
6. Rajasekaran A, Thampi PP. Synthesis and antinociceptive 
activity of some substituted-5-[2-(1,2, 3,4-tetrahydrocarbazol-
9-yl)ethyl]tetrazol-1-ylalkanones. Eur J Med Chem 
2005:40(12):1359–64. 
7. Demarinis RM, Hoover JRE, Dunn GL. A new parenteral 
cephalosporin. SK&F 59962:7-trifluoromethylthioacetamido-3-
(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cepham-4-carboxylic 
acid. Chemistry and structure activity relationships. J 
Antibiotics 1975:28 (6): 463–70. 
8. Upadhayaya RS, Jain S, Sinha N, Kishore N, Chandra R, Arora SK. 
Synthesis of novel substituted tetrazoles having antifungal 
activity. Eur J Med Chem 2004:39(7):579–92. 
9. Dlugosz A. Synthesis and biological activity of 
pyrimidobenzodiazepine derivatives. New ring systems: 
triazolo-and tetrazolo-pyrimidobenzodiazepines. Pharmazie 
1995:50(3):180–2. 
10. Knaus EE, Kumar P. Synthesis and anti-inflammatory activity of 
5-(1,2-dihydropyridyl)-tetrazol-2-aceticacids, esters and 
amides, Eur J Med Chem 1993:28(11):881–5. 
11. Terashima K, Tanimura T, Shimamura H. Studies on antiulcer 
agents. II. Antiulcer properties of N-(1H-tetrazol-5-yl)-2-
anilino-5-pyrimidinecarboxamides inhibiting release of 
histamine from passively sensitized rat peritoneal mast cells. 
Chem Pharm Bulletin 1995:43(6):1042–4. 
12. Gundugola AS, Chandra KL, Perchellet EM, Waters AM, 
Perchellet JPH, Rayat S. Synthesis and antiproliferative 
evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl 
tetrazoles, Bioorg Med Chem Lett 2010:20(13):3920–24. 
13. Nohara A, Kuriki H, Saijo T, Sugihara H, Kanno M, Sanno Y. 
Studies on antianaphylactic agents. 5: Synthesis of 3-(1H-
tetrazol-5-yl)chromones, a new series of antiallergic 
substances. J Med Chem 1997:20(1):141–5. 
14. Rajasekaran A, Thampi PP. Synthesis and analgesic evaluation 
of some 5-[-(10-phenothiazinyl) ethyl]-1-(acyl)-1,2,3,4-
tetrazoles. Eur J Med Chem 2004:39(3):273–9. 
 
